Biotech

All Articles

ReNeuron leaving AIM exchange after skipping fundraising objective

.ReNeuron has joined the long checklist of biotechs to leave behind Greater london's goal stock exch...

MBX apply for IPO to take opposition to Ascendis in to phase 3

.MBX Biosciences has actually added to the latest outbreak of IPO filings. The biotech, which submit...

FDA grows probe into Lykos' MDMA trials: WSJ

.For Lykos Therapies and also the provider's potential MDMA-assisted therapy for trauma (POST-TRAUMA...

Gene editor Volume laying off 131 employees

.Just days after genetics publisher Tome Biosciences announced undisclosed functional slices, a more...

Repare lays off 25% of personnel as biotech standstills preclinical R&ampD

.Repare Therapeutics is giving up a fourth of its own labor force as the oncology biotech downsize i...

J &amp J apply for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken another action toward realizing a yield on its $6.5 billion nipocali...

Gain's phase 1 gain paves means to verify Parkinson's medicine's worth

.Increase Rehabs has specified its own sights on verifying the efficiency of its Parkinson's illness...

Actinogen documents brand new period 2 information to restore clinical depression drug

.Actinogen Medical's chances-- and also inventory rate-- have recoiled slightly from earlier this mo...

Pfizer and also Flagship add Ratio to multibillion-dollar formula

.Front Runner Pioneering and Pfizer have actually added Ratio right into their 10-program alliance, ...

Bayer pens $547M deal to push boundaries of noncoding RNA

.Bayer executives were keen to worry to Ferocious this summer months that the German pharma titan's ...